(The Hill) — President Donald Trump on Thursday announced a slew of product-specific tariffs set to take effect on Oct. 1, including duties on any pharmaceuticals whose manufacturers don't have plants in the United States.

The tariffs, which are on top of sweeping reciprocal duties Trump has imposed on countries worldwide, are likely to spur criticism, particularly when it comes to pharmaceutical imports. Experts have raised concerns that those tariffs could cause supply chain issues and make certain drugs more difficult and expensive to acquire.

"Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America," Trump posted on Truth Social.

Trump added that

See Full Page